Pharmaceutical Technology
April 02, 2008
Online Exclusive
32
4
A reference book omits important information and ignores advanced testing procedures.
April 02, 2008
PharmTech Talk
32
4
The economic case for personalized medicine offers a solution to the industry's recent woes.
April 02, 2008
Agent-In-Place
32
4
Essential components of a good inspection: good ingredients, proper inserts, and ... deer?
April 02, 2008
Inside IPEC
32
4
A changing regulatory environment is on the horizon for excipient suppliers and users.
April 02, 2008
Ingredients Insider
32
4
Moderate growth is projected for the global excipients market. Excipient producers target blends and new grades for improving functionality and performance.
April 02, 2008
News
32
4
Although there have been recent setbacks for China with regard to exported products, the country has made substantial strides in its pharmaceutical industry over the past few years. Intense competition and a series of new regulations seem to be moving the country into a period of recovery.
April 02, 2008
Outsourcing
32
4
The recent heparin contamination event calls for a new approach to manage a lengthening pharmaceutical supply chain.
April 02, 2008
Peer-Reviewed Research
32
4
The authors developed a reliable spectrophotometric method for determining and measuring trace amounts of lead in various samples.
April 02, 2008
From The Editor
32
4
The FDA itself issues a cry for help. Is anybody listening?
April 02, 2008
Online Exclusive
32
4
Excipient producers and industry observers share their perspectives on innovation for excipients.
April 02, 2008
News
32
4
Antibodies are highly specific molecules that can be tailored to recognize almost any stretch of peptide that nature can conjure: a feature that has been exploited for years now to produce therapeutic antibodies.
April 02, 2008
News
32
4
Sophisticated replication techniques have made counterfeiting and fraud a serious threat to the pharmaceutical industry.
April 02, 2008
Peer-Reviewed Research
32
4
Regulatory agencies expect companies to establish and monitor clean equipment- and dirty equipment-hold times for manufacturing equipment as part of their cleaning validation program.
April 02, 2008
Viewpoint
32
4
Was FDA's decision to issue a draft guidance on of-label information, amidst Congressional scrutiny, the right thing to do?
April 02, 2008
Packaging Forum
32
4
The annual show provided one-stop shopping for packaging equipment and materials.
April 02, 2008
Special Report
32
4
Companies continue to develop inhaled insulin and other drugs, despite the problems that Pfizer's "Exubera" experienced.
April 02, 2008
In the Spotlight
32
4
Manufacturers expect to see the latest developments in process equipment at INTERPHEX, and this year's show was no disappointment. Exhibitors regularly display additions to their lines of encapsulators, tablet presses, material-handling machines, and other automated manufacturing equipment. But the products on view in Philadelphia Mar. 26–28 were not limited to manufacturing applications.
April 02, 2008
Online Exclusive
32
4
Undertaking process validation involves a major commitment in terms of personnel, resources, time, and money. Performing prerequisite verifications can reduce the risk of making costly mistakes. This Part 1 article explains the value of performing prerequisite verifications and presents case-study examples and real-world solutions to avoid costly process validation failures.
April 02, 2008
Online Exclusive
32
4
What makes a drug ripe for respiratory delivery?
April 02, 2008
Washington Report
32
4
Heparin contamination casts a shadow on regulatory oversight of product quality.